Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Perception, Risk Behaviour, and Attitudes Related to Non-communicable Disease

29 maggio 2026 aggiornato da: Li Ho Cheung William, Chinese University of Hong Kong

Understanding of the Perception, Risk Behaviour, and Attitudes Related to Non-communicable Disease Among Adolescents and Young Adults: An Exploratory Study

The study is to explore the understanding of the perception, risk behaviour, and attitudes related to non-communicable diseases among adolescents and young adults. The objectives of the study are:

  1. To investigate the understanding of non-communicable diseases among adolescents and young adults;
  2. To identify the prevalence of health-risk behaviours among adolescents and young adults;
  3. To examine the attitudes and behaviours to prevent non-communicable diseases among adolescents and young adults

Panoramica dello studio

Descrizione dettagliata

Chronic diseases, also known as non-communicable diseases (NCDs), are the leading causes of global morbidity and mortality, accounting for around 74% of all deaths worldwide. Cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes contribute to over 80% of premature NCD-related deaths. The World Health Organization identifies four key modifiable behavioural risk factors-tobacco use, harmful alcohol consumption, unhealthy diets, and physical inactivity-as major contributors to NCDs. Evidence shows that most premature deaths from NCDs are preventable through targeted interventions and sustainable lifestyle changes. In Hong Kong, the burden of NCDs is growing, driven by an aging population. The Hospital Authority projects a 50% increase in NCD cases among the middle-aged, rising from 2 million in 2019 to 3 million by 2039, posing a serious challenge to the healthcare system. In response, the government has pledged to strengthen district-based primary healthcare services, including establishing health centres across all districts and launching the Chronic Disease Co-Care Pilot Scheme in 2023 for adults aged 45 and above.

However, adolescence represents a critical developmental window characterized by rapid biological, cognitive, and emotional changes, as well as heightened exposure to social stressors. This stage is particularly vulnerable to the adoption of risk behaviours that often persist into adulthood and contribute to chronic health conditions. Notably, 97.4% of smokers in Hong Kong began smoking before age 30, underscoring the importance of early intervention. These findings highlight the need to initiate education and screening efforts at a younger age. The adage "an ounce of prevention is worth a pound of cure" is especially pertinent in public health. Reflecting this, the Hong Kong Government is transitioning its healthcare model from treatment-focused to prevention-oriented. Prioritizing early intervention during youth is essential for promoting lifelong health and well-being and represents one of the most effective strategies for reducing the prevalence of NCDs in Hong Kong.

Aim of Study

The aim of the study is to explore the understanding of the perception, risk behaviour, and attitudes related to non-communicable diseases among adolescents and young adults. The objectives of the study are:

  1. To investigate the understanding of non-communicable diseases among adolescents and young adults;
  2. To identify the prevalence of health-risk behaviours among adolescents and young adults;
  3. To examine the attitudes and behaviours to prevent non-communicable diseases among adolescents and young adults

Outcome measures Primary outcomes: Information on four major health-risk behaviours including tobacco use, harmful use of alcohol, an unhealthy diet and physical inactivity, and lifestyle practices associated with prevention and control of non-communicable diseases (NCDs)

In what way will the research contribute to knowledge or healthcare development? The findings of this study will contribute to the development of appropriate interventions that targeting adolescents and young adults with health-risk behaviours with the aim to help them quit health-risk behaviours and adopt a healthy lifestyle.

Study subjects Inclusion criteria

  1. Aged 18 to 45 years
  2. Able to speak Cantonese

Exclusion criteria

  1. Studying medical, nursing and healthcare-related courses or working in medical, nursing, and allied health fields
  2. Those who had been diagnosed with NCDs

How will subjects be identified and recruited: To enhance the representativeness of the sample, we aim to recruit participants from all the 18 districts in the community.

Measures: A modified behavioural health-risk factor survey was used to collect demographic data and information regarding health-risk behaviours. The survey was a checklist adopted from the Hong Kong Department of Health (www.chp.gov.hk/files/pdf/brfs_2015apr_en.pdf, accessed on 5 January 2021).

Methods of Data Analysis Data will be entered into SPSS for Windows (version 28). A logic check program will be installed for entry validation. Descriptive statistics such as frequency, percentage, and mean will be used to summarize the outcomes and other variables. Chi-square tests and t-tests will be used to compare outcome variables between subgroups. The Pearson product moment correlation coefficient will be used to investigate the interrelationships.

Tipo di studio

Osservativo

Iscrizione (Stimato)

5000

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

      • Hong Kong, Hong Kong
        • Reclutamento
        • The Nethersole School of Nursing, The Chinese University of Hong Kong
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto

Accetta volontari sani

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

About 5,000 young adults in Hong Kong without non-communicable diseases

Descrizione

Inclusion Criteria:

  • (1) Aged 18 to 45 years
  • (2) Able to speak Cantonese

Exclusion Criteria:

  • (1) Studying medical, nursing and healthcare related courses or working in medical, nursing, and allied health fields
  • (2) Those who had been diagnosed with non-communicable diseases

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Information on four major health risk behaviours
Lasso di tempo: Baseline
Information on four major health risk behaviours including tobacco use, harmful use of alcohol, an unhealthy diet and physical inactivity, and lifestyle practices associated with prevention and control of non-communicable diseases (NCDs), will be collected by using a modify behavioural health-risk factor survey. Data on tobacco use, alcohol consumption, fruit and vegetable intake, physical activity levels, and relevant lifestyle practices will be analysed to determine whether participants meet the World Health Organization (WHO) targets for the prevention and control of non-communicable diseases.
Baseline

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

29 maggio 2026

Completamento primario (Stimato)

31 agosto 2026

Completamento dello studio (Stimato)

31 agosto 2026

Date di iscrizione allo studio

Primo inviato

13 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

13 maggio 2026

Primo Inserito (Effettivo)

19 maggio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

2 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

29 maggio 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi